SUPN - Supernus Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts7777
Avg. Estimate0.60.652.192
Low Estimate0.530.572.091.6
High Estimate0.640.742.322.35
Year Ago EPS0.520.482.052.19
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts7777
Avg. Estimate109.54M119.53M413.82M447.6M
Low Estimate105.7M114.42M403.99M430M
High Estimate116.3M130M419.58M466.8M
Year Ago Sales103M115.93M408.9M413.82M
Sales Growth (year/est)6.40%3.10%1.20%8.20%
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.0.410.270.470.58
EPS Actual0.520.480.340.61
Difference0.110.21-0.130.03
Surprise %26.80%77.80%-27.70%5.20%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate0.60.652.192
7 Days Ago0.60.652.192
30 Days Ago0.60.642.192
60 Days Ago0.610.642.192.14
90 Days Ago0.630.712.262.63
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/A1N/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesSUPNIndustrySectorS&P 500
Current Qtr.15.40%N/AN/A-0.02
Next Qtr.35.40%N/AN/A0.07
Current Year6.80%N/AN/A-0.02
Next Year-8.70%N/AN/A0.14
Next 5 Years (per annum)37.00%N/AN/A0.07
Past 5 Years (per annum)59.68%N/AN/AN/A